Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Cardiorenal Medicine|May 26, 2023
Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure RegistryJuan David López-Ponce de León, Juan Esteban Gómez-Mesa, Clara Saldarriaga, et al.
Acta Cardiologica|August 15, 2024
Impact of sex on clinical and laboratory parameters in patients with heart failure: insights from the Colombian Heart Failure Registry (RECOLFACA)Clara Saldarriaga, Alex Rivera-Toquica, Eduardo José Echeverry-Navarrete, et al.
International Journal of Cardiology. Heart & Vasculature|July 19, 2024
Eligibility of sodium-glucose cotransporter-2 inhibitors in heart failure with preserved ejection fraction: Insights from the Colombian heart failure registry (RECOLFACA)Juan Esteban Gómez-Mesa, Clara Saldarriaga, Alex Arnulfo Rivera-Toquica, et al.
Nature Biotechnology|October 19, 2021
High-throughput functional characterization of protein phosphorylation sites in yeastCristina Viéitez, Bede P Busby, David Ochoa, et al.
Nucleic Acids Research|November 14, 2025
EMBL's European Bioinformatics Institute (EMBL-EBI) in 2025Matthew Thakur, Nicolas Bosc, Cath Brooksbank, et al.
Nucleic Acids Research|November 16, 2020
Open Targets Platform: supporting systematic drug-target identification and prioritisationDavid Ochoa, Andrew Hercules, Miguel Carmona, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
The Human Pleiotropic Map of GWAS Associations and Therapeutic ImplicationsYakov A Tsepilov, Daniel Suveges, Daniel Considine, et al.
Nucleic Acids Research|December 10, 2024
Open Targets Platform: facilitating therapeutic hypotheses building in drug discoveryAnnalisa Buniello, Daniel Suveges, Carlos Cruz-Castillo, et al.
Nucleic Acids Research|November 18, 2022
The next-generation Open Targets Platform: reimagined, redesigned, rebuiltDavid Ochoa, Andrew Hercules, Miguel Carmona, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Cell-type-resolved genetic regulatory variation shapes inflammatory bowel disease riskTobi Alegbe, Bradley T Harris, Laura Fachal, et al.
Pageof 11